The Food and Drug Administration today authorized the Moderna and Pfizer bivalent COVID-19 vaccines for emergency use in children as young as 6 months old. Specifically, the agency authorized the Moderna vaccine as a single booster dose for children aged 6 months through 5 at least two months after primary vaccination, and the Pfizer vaccine for children aged 6 months through 4 who have not yet received the third primary series dose. Before providers can start administering the bivalent doses, the Centers for Disease Control and Prevention must recommend them for these age groups.

Related News Articles

Headline
Iowa, Massachusetts, Maryland, Michigan, Minnesota and New Mexico will participate in a new Department of Health and Human Services collaborative that will…
Headline
The Department of Health and Human Services Feb. 14 named several hospital and health system programs final phase winners in its national competition to…
Headline
Syphilis infections during pregnancy more than tripled between 2016 and 2022 to 280 cases per 100,000 births, ranging from 46 per 100,000 in Maine to 763 per…
Headline
Learn how hospitals and health systems are improving maternal and child health outcomes in this synopsis of the latest resources from AHA’s Better Health for…
Headline
In the latest episode of the AHA series “Beyond Birth,” clinical social worker Laura La Porte and new mom Anna Ma discuss how the Perinatal Depression Program…
Headline
A CDC study  released Dec. 21 found low COVID-19 and flu vaccination coverage for most adults, and low RSV vaccination coverage for adults aged 60 and…